The Impact of Delay in Treatment on Survival in Surgically Managed Sinonasal Undifferentiated Carcinoma

Abstract

Background Sinonasal undifferentiated carcinoma (SNUC) is a rare, aggressive malignancy with a poor prognosis, and multimodal therapy is the standard of care. We sought to characterize treatment delays in SNUC managed with surgery and adjuvant radiation and to determine the impact on survival using the National Cancer Database (NCDB).

Methods This was a retrospective, population-based cohort study of patients with SNUC between 2004 and 2016 in the NCDB. The intervals of diagnosis to surgery (DTS), surgery to radiation (SRT), and radiation duration (RTD) were examined. Recursive partitioning analysis (RPA) was performed to identify the variables with the greatest impact on survival. The association between treatment delay and overall survival (OS) was then assessed using multivariate Cox proportional hazards regression.

Results Of 173 patients who met inclusion criteria, 65.9% were male, average age at diagnosis was 56.6 years, and 5-year OS was 48.1%. Median durations of DTS, SRT, and RTD were 18, 43, and 46 days, respectively. Predictors of treatment delay included Black race, government insurance excluding Medicare/Medicaid, and positive margins. RPA-derived optimal thresholds were 29, 28, and 38 days for DTS, SRT and RTD, respectively. On multivariate analysis, positive margins (hazard ratio [HR]: 4.82; 95% confidence interval [CI]: 2.28–10.2) and DTS less than 29 days (HR: 2.41; 95% CI: 1.23–4.73) were associated with worse OS.

Conclusion Our results likely reflect the aggressive nature of the disease with surgeons taking more invasive disease to the operating room more quickly. Median treatment intervals described may serve as relevant national benchmarks.

Keywords

sinonasal undifferentiated carcinoma - cancer - treatment delays - survival

Publication History

Received: 30 March 2022

Accepted: 20 June 2022

Article published online:
25 August 2022

• References

• 1 Reiersen DA, Pahilan ME, Devaiah AK. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. In: Otolaryngology - Head and Neck Surgery 2012; 147 (01) 7-14
• 2 Gamez ME, Lal D, Halyard MY. et al. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): the Mayo Clinic experience. Head Neck 2017; 39 (09) 1819-1824
• 3 Ahn PH, Mitra N, Alonso-Basanta M. et al. Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis. Br J Radiol 2016; 89 (1058): 20150488
• 4 Pisani P, Airoldi M, Allais A. et al. Metastatic disease in head & neck oncology. Acta Otorhinolaryngol Ital 2020; 40 (02, Suppl 01) S1-S86
• 5 Xu CC, Dziegielewski PT, McGaw WT, Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg 2013; 42 (JAN): 2
• 6 Chambers KJ, Lehmann AE, Remenschneider A. et al. Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. J Neurol Surg B Skull Base 2015; 76 (02) 94-100
• 7 Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 2005; 12 (03) 134-143
• 8 Khan MN, Konuthula N, Parasher A. et al. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the National Cancer Database. Int Forum Allergy Rhinol 2017; 7 (02) 205-210
• 9 Cooper JS, Porter K, Mallin K. et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009; 31 (06) 748-758
• 10 Leblanc M, Crowley J. Relative Risk Trees for Censored Survival Data. Vol 48. 1992. Accessed July 11, 2022 at: https://about.jstor.org/terms
• 11 Fors MM, Viada CE, Gonzalez P. Use of recursive partitioning analysis in clinical trials and meta-analysis of randomized clinical trials, 1990-2016. Rev Recent Clin Trials 2017; 12 (01) 3-7
• 12 Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 2009; 14 (04) 323-348
• 13 Goel AN, Lee JT, Wang MB, Suh JD. Treatment delays in surgically managed sinonasal cancer and association with survival. Laryngoscope 2020; 130 (01) 2-11
• 14 Agarwal P, Jones EA, Devaiah AK. Education and insurance status: Impact on treatment and survival of sinonasal cancer patients. Laryngoscope 2020; 130 (03) 649-658
• 15 Carey RM, Parasher AK, Workman AD. et al. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: analysis from the national cancer database. Laryngoscope 2018; 128 (03) 560-567
• 16 O'Keefe EB, Meltzer JP, Bethea TN. Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. Front Public Health 2015; 3: 51
• 17 Daraei P, Moore CE. Racial disparity among the head and neck cancer population. J Cancer Educ 2015; 30 (03) 546-551
• 18 Ranasinghe VJ, Stubbs VC, Reny DC, Fathy R, Brant JA, Newman JG. Predictors of nodal metastasis in sinonasal squamous cell carcinoma: a national cancer database analysis. World J Otorhinolaryngol Head Neck Surg 2020; 6 (02) 137-141
• 19 Morse E, Berson E, Fujiwara R, Judson B, Mehra S. Hypopharyngeal cancer treatment delays: benchmarks and survival association. Otolaryngol Head Neck Surg 2019; 160 (02) 267-276
• 20 Morse E, Judson B, Husain Z. et al. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation. Oral Oncol 2018; 82: 122-130
• 21 Morse E, Judson B, Husain Z. et al. Treatment delays in primarily resected oropharyngeal squamous cell carcinoma: national benchmarks and survival associations. Otolaryngol Head Neck Surg 2018; 159 (06) 194599818779052
• 22 Naghavi AO, Echevarria MI, Strom TJ. et al. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol 2016; 45: 18-25
• 23 Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006; 116 (07) 1093-1106
• 24 Sequist TD, Cullen T, Acton KJ. Indian Health Service innovations have helped reduce health disparities affecting american Indian and Alaska native people. Health Aff (Millwood) 2011; 30 (10) 1965-1973
• 25 Agha Z, Lofgren RP, Vanruiswyk JV, Layde PM. Are patients at veterans affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 2000; 160 (21) 3252-3257
• 26 Muvuka B, Combs RM, Ayangeakaa SD, Ali NM, Wendel ML, Jackson T. Health literacy in African-American communities: barriers and strategies. Health Lit Res Pract 2020; 4 (03) e138-e143
• 27 Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990; 160 (04) 410-414
• 28 Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg 2014; 151 (06) 984-990
• 29 Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL. Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract 2017; 13 (04) e319-e328
• 30 Goel AN, Frangos M, Raghavan G. et al. Survival impact of treatment delays in surgically managed oropharyngeal cancer and the role of human papillomavirus status. Head Neck 2019; 41 (06) 1756-1769
• 31 Abdelmeguid AS, Bell D, Hanna EY. Sinonasal undifferentiated carcinoma. Curr Oncol Rep 2019; 21 (03) 26